Css LLC Clovis Oncology, Inc. Put Options Transaction History

Css LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $666,185 - $1.43 Million	-138,500 Reduced 93.27%	10,000 $70,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $284,500 - $484,500	-50,000 Reduced 25.19%	148,500 $1 Million
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $97,266 - $283,800	-25,800 Reduced 11.5%	198,500 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $366,900 - $2.01 Million	122,300 Added 119.9%	224,300 $2.34 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $112,791 - $440,545	28,700 Added 39.15%	102,000 $400,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $631,533 - $1.27 Million	49,300 Added 205.42%	73,300 $1.09 Million
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $141,280 - $242,240	8,000 Added 50.0%	24,000 $595,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $69,780 - $196,020	-6,000 Reduced 27.27%	16,000 $287,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $587,400 - $989,599	20,000 Added 1000.0%	22,000 $645,000
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $744,462 - $1.1 Million	-17,700 Reduced 89.85%	2,000 $90,000
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $175,420 - $237,020	-3,500 Reduced 15.09%	19,700 $1.04 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $288,450 - $422,900	-5,000 Reduced 17.73%	23,200 $1.58 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.89 Million - $2.39 Million	28,200	28,200 $2.32 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.